Diclofenac Transdermal Patch and Azilsartan: Interaction Details

Brand names
Diclofenac Transdermal Patch
Flector PatchLicart Topical SystemZorvolex +12 more
Azilsartan
Edarbi
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page

A close look at the Diclofenac Transdermal Patch and Azilsartan interaction:

Share

Share this interaction

Diclofenac Transdermal Patch

Brand names
  • Flector Patch
  • Licart Topical System
  • Zorvolex
  • Pennsaid
  • Licart
  • Aleve Arthritis Pain
  • Lofena
  • Xiclo
  • Flector
  • Voltaren
  • Cataflam
  • Zipsor
  • Cambia
  • diclofenac epolamine
  • Diclox Patch 30CT

What Happens When You Take Diclofenac Transdermal Patch With Azilsartan

What can happen when they are taken together (rated Moderate)

Reduced antihypertensive effect and dysfunction and/or increased blood pressure

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

(ARBs) and may have their natriuretic and blood pressure lowering actions diminished by . In certain patients, giving these agents together may also lead to worsening kidney function, which can include acute renal failure.

If the combination cannot be avoided, decide at the start of therapy whether renal function monitoring is needed, watch for adequate antihypertensive response, and periodically evaluate renal function for evidence of decline or failure, particularly in older patients, when treatment is first started, in those who are volume depleted, and in those with existing renal impairment. Patients should be kept adequately hydrated.3214

The Diclofenac Transdermal Patch and Azilsartan Interaction, Explained

Diclofenac patches (like Flector or Licart) are anti-inflammatory pain relievers. Azilsartan (Edarbi) lowers blood pressure. Used together, the diclofenac can make azilsartan a little less effective, so your blood pressure may creep up. In some people, especially older adults, people who are dehydrated, or people who already have kidney problems, the two together can also put extra strain on the kidneys.

A patch sends much less medicine into your blood than a pill, but it still counts. The good news is that your care team can manage this. Keep taking both as prescribed, drink enough fluids, and let your pharmacist or doctor know you use both.

Mechanism: . of COX reduces prostaglandin synthesis, blunting the antihypertensive and natriuretic effect of and compounding effects on glomerular perfusion (reduced afferent vasodilation plus ARB-mediated efferent dilation).

  • Effect: Reduced BP control; possible renal deterioration, including acute renal failure in susceptible patients.
  • Severity/evidence: Moderate; established (NSAID/ARB class effect). Onset unspecified. Systemic diclofenac exposure from transdermal patches is low relative to oral dosing, which may lessen but does not eliminate risk.
  • Management: Assess need for baseline renal function at initiation, monitor BP response, and check renal function periodically, particularly in elderly, volume-depleted, or renally impaired patients and during initiation. Ensure adequate hydration.

See the 9 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Diclofenac Transdermal Patch and Azilsartan Interact

The likely mechanism

effects on function; decreased renal prostaglandin production

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Diclofenac Transdermal Patch and Azilsartan Interaction

Many people use these two medicines together safely. Here is what typically happens:

  • Your care team may check your kidney function when the patch is started and from time to time afterward, and may keep a closer eye on your blood pressure.
  • Extra attention is common if you are older, have kidney problems, or could be low on fluids.
  • What you can do: Keep taking both as prescribed and stay well hydrated.
  • Tell your pharmacist or prescriber if your home blood pressure readings rise, or if you have been sick with vomiting, diarrhea, or poor fluid intake.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Diclofenac Transdermal Patch or Azilsartan need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there anything you'd monitor while I'm on both?

Literature Reports

4 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Indomethacin-enalapril interaction: an alert (letter)

    A 48-year-old man with hypertension, whose blood pressure had previously been well-controlled on enalapril 10 mg/day, developed severe hypertension, psychosis, disorientation, and generalized anasarca four days after starting indomethacin 100 mg/day for gout.5 Raising the enalapril dose to 20 mg/day failed to control the hypertension, and indomethacin was stopped.

    The following day, the patient underwent rapid diuresis and substantial weight loss. Enalapril was subsequently decreased to 10 mg/day, with good hypertension control and no remaining psychosis.6

  2. Report 2 · Study title

    Effect of indomethacin on blood pressure lowering by captopril and losartan in hypertensive patients

    In a randomized, double-blind, parallel-design multicenter study of 141 hypertensive patients, indomethacin opposed the antihypertensive action of captopril. After one week of combined indomethacin and captopril therapy, 24-hour systolic blood pressure rose by 4.6 mmHg and diastolic blood pressure by 2.7 mmHg (p less than 0.001). In total, ambulatory diastolic blood pressure increased in 67% of captopril-treated patients while they were receiving indomethacin.7

  3. Report 3 · Study title

    Effect of rofecoxib on the antihypertensive activity of lisinopril (letter)

    A 59-year-old man who had been receiving lisinopril 10 mg/day for 5 years experienced worsening hypertension after starting rofecoxib 25/day for arthritic pain. Within 5 weeks, his blood pressure rose from 130 to 135/80 to 85 to 168/98.

    Rofecoxib was discontinued, and blood pressure fell over the next 18 days (average, 127/78 mmHg). Because of worsening joint pain, rofecoxib was reinstated at 25 mg/day.

    Blood pressure rose after 2 days of treatment and averaged 143/89 mmHg during the subsequent 2 weeks. The lisinopril dose was raised to 20 mg/day, after which blood pressure averaged 121/81 mmHg over the following 21 days.8

  4. Report 4 · Study title

    Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors

    In a double-blind, placebo-controlled, parallel-group trial involving 178 hypertensive patients, celecoxib did not diminish the antihypertensive effect of lisinopril. Participants were given celecoxib 200 mg twice daily or placebo alongside their usual lisinopril regimen (10 to 40 mg daily) for 4 weeks.

    Changes from baseline in 24-hour systolic and diastolic blood pressure (BP) were not significant. The proportions of patients whose 24-hour BP rose by at least 5, 10, 15, or 20 mmHg were likewise comparable between celecoxib and placebo. The placebo-subtracted changes in 24-hour BP (1.6/1.2 mmHg) were smaller than those previously reported for in patients treated with .9

Diclofenac Transdermal Patch and Azilsartan: Common Questions

How serious is the Diclofenac Transdermal Patch and Azilsartan interaction?

It is rated moderate. Can be significant — usually manageable with monitoring.

How is the Diclofenac Transdermal Patch and Azilsartan interaction managed?

Many people use these two medicines together safely. Here is what typically happens: Your care team may check your kidney function when the patch is started and from time to time afterward, and may keep a closer eye on your blood pressure. Extra attention is common if you are older, have kidney problems, or could be low on fluids. What you can do: Keep taking both as prescribed and stay well hydra… Management is individual — always follow your own care team's guidance.

Who is at higher risk from the Diclofenac Transdermal Patch and Azilsartan interaction?

The interaction record names these groups as more likely to be affected:

  • Older adults
  • People with kidney problems

If this describes you, tell your pharmacist or prescriber.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "established". Well documented — supported by controlled studies or strong clinical data.

Ask About the Diclofenac Transdermal Patch and Azilsartan Interaction

Ask in your own words about taking Diclofenac Transdermal Patch and Azilsartan together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (9)

  1. Product Information: CALDOLOR(R) intravenous injection, ibuprofen intravenous injection. Cumberland Pharmaceuticals Inc. (per FDA), Nashville, TN, 2016. DailyMed
  2. Product Information: SPRIX(R) nasal spray, ketorolac tromethamine nasal spray. Egalet US Inc. (per FDA), Wayne, PA, 2016. DailyMed
  3. Product Information: Dynastat intravenous injection, intramuscular injection, parecoxib sodium intravenous injection, intramuscular injection. Pfizer Australia Pty Ltd (per Australian Register of Therapeutic Goods), West Ryde, Australia, 2017. DailyMed
  4. Product Information: meloxicam oral tablets, meloxicam oral tablets. Apotex Corp. (per DailyMed), Weston, FL, 2016. DailyMed
  5. Ahmad S: Indomethacin-enalapril interaction: an alert (letter). South Med J 1991; 84:411-412. PubMed
  6. Morgan T, Anderson A, & Bertram D: Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril. Am J Hypertens 2000; 13:1161-1167. PubMed
  7. Conlin P, Moore T, Swartz S, et al: Effect of indomethacin on blood pressure lowering by captopril and losartan in hypertensive patients. Hypertension 2000; 36:461-465. DOI
  8. Brown C: Effect of rofecoxib on the antihypertensive activity of lisinopril (letter). Ann Pharmacother 2000; 34:1486. PubMed
  9. White W, Kent J, Taylor A, et al: Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors. Hypertension 2002; 39:929-934. PubMed
Was this write-up helpful?

Other Serious Interactions of Diclofenac Transdermal Patch and Azilsartan

Also serious with Diclofenac Transdermal Patch

Also serious with Azilsartan

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Azilsartan

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring.
  • Moderate Can be significant — usually manageable with monitoring. This interaction.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data. This interaction.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.